Table 2.

Diabetes management and diabetes-related complications in individuals with WRS

	n data available	median [Q1-Q3] or %
Manifestation with diabetic ketoacidosis	10	70
Insulin dose at manifestation (IU/kg/d)	6	0.7 [0.5–0.9]
Insulin dose at follow-up (IU/kg/d)	11	0.7 [0.5–1]
HbA1c at manifestation (%)	5	7 [5.8–10.9]
HbA1c at follow-up (%)	11	8 [7–9]
≥ 1 episodes of SH during follow-up	10	40
≥ 1 episodes of DKA during follow-up	10	10